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Ultraviolet (UV) 1 light (280-340  nm) irradiation of mice results in immuno- 
logic alterations that are dependent on the dose and time course of the radiation. 
Acute UV irradiation  regimens (less than  -14  daily exposures) are associated 
with tolerance to topically applied skin contact sensitizers (1-8). If the acute UV 
regimen is performed with low-dose radiation (~0.01-0.35 J/cm 2 per exposure), 
the tolerance is "site specific" in that it is manifest only if the antigen is introduced 
through  UV-irradiated  skin  (1,  2,  5).  However,  if high,dose UV  radiation  is 
employed (greater than -0.5 J/cm 2 per exposure), systemic tolerance results (4, 
5, 7), and the specific contact sensitizing antigen can be applied to unirradiated 
skin sites and no delayed-type hypersensitivity (DTH) reaction is elicited upon 
subsequent challenge. If UV exposures are administered chronically (4-8  wk), 
the capacity to manifest DTH through UV-irradiated skin reappears (3). 
Our  interest  in  immunological aberrations  associated  with  UV  irradiation 
stems from our studies in UV-induced susceptibility to skin tumors. It is reason- 
able that the immunological dysfunctions associated with acute UV irradiation, 
measured in terms of DTH unresponsiveness (1-8), diminished antigen presen- 
tation capacity (9-15),  altered cell distributions (15), and elevated acute phase 
reactants (16),  might play a  role in the subsequent development of the tumor- 
susceptible state. The data to be presented in this report address another facet 
of early  immunologic changes associated  with acute low-dose  UV  irradiation. 
We  have  investigated  the  role  of UV  exposure  in  the  induction of humoral 
tolerance to soluble protein antigens.  Our results suggest that  UV irradiation 
can inhibit antibody responses initiated by skin-priming with antigen (17).  We 
have termed this phenomenon "phototolerance" (PT). Our rationale for selecting 
soluble  protein  antigens  was  the  possible  clinical  relevance  of such  protocols 
where  tolerance  to  a  variety  of soluble  antigens  might be  inducd.  Examples 
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include, but are not limited to, monoclonal antibodies or enzymes administered 
for therapeutic reasons and transplantation antigens to inhibit organ rejection. 
Materials and  Methods 
Mice.  C3Hf/HeN female mice were purchased from Charles River Breeding Labora- 
tories,  Inc.,  Wilmington,  MA.  BALB/c  mice  were  obtained  from  our  own  breeding 
colony. Groups of four age-matched animals, 6-8 wk old, were used in all experiments. 
Bleeding was performed by puncturing the retro-orbital plexus while the animals were 
under light ether anesthesia.  Serum samples from the mice in each group were pooled 
and stored frozen until analysis. 
UV Irradiation  of Mice.  Details of the  UV irradiation  of mice have been published 
previously (18).  Briefly, the  UV  source consisted  of a  bank  of six  FS-40  fluorescent 
sunlamps  (Westinghouse  Electric  Corp.,  Pittsburgh,  PA)  emitting  principally  (>60%) 
between 280 and 320 nm. The energy output, from a distance of 20 cm, was ~2 J/m2-s. 
Mice were irradiated for 30 min/d.  Dorsal skin sites were exposed by removing the fur 
with clippers. 
Skin Sensitization.  Antigen was introduced by scarification of several square millimeters 
of UV-irradiated  skin.  Our protocol  involved placing 20  ~1  phosphate-buffered saline 
(PBS) containing 20 ~g antigen on a patch of irradiated skin. A 27 gauge needle was used 
to stroke the area. Scarification was complete when the solution had been evenly distrib- 
uted and absorbed onto the skin. 
Induction  of PT.  Mice were UV-irradiated four times, for 30 min/d, prior to being 
skin-sensitized with antigen. Mice that received multiple sensitizations with antigen were 
maintained on the UV irradiation regimen until the last sensitization was performed. The 
term "PT induction" is defined as the process of UV-irradiating and skin-sensitizing the 
mice. 
Antigen  Challenge.  Mice were challenged by injecting 0.2  ml PBS containing  50 t~g 
antigen intraperitoneally.  The particular immunization schedules used are indicated in 
each data table. 
Antigens.  Human or rabbit IgG was purchased from Sigma Chemical Co. (St.  Louis, 
MO). These materials were further purified by DEAE cellulose (Whatman, Ltd.,  Kent, 
England) and Sephacryl S-300 (Pharmacia Fine Chemicals, Piscataway, N  J) chromatogra- 
phy. Conaibumin (Sigma Chemical Co.) was used without further purification. 
During these investigations, we examined a range of  antigen concentrations for inducing 
PT and eliciting antibody responses. 50 #g of human IgG, rabbit IgG, or conalbumin was 
optimal for antigen challenge. PT was readily induced over a dose range of 2-100 #g of 
antigen.  The  results  presented  here  are  based  on  the  use  of  20  #g  of antigen  for 
sensitization. 
Quantitation  of Antibody Activity.  The specific antibody titer of pooled mouse sera was 
determined using an enzyme-linked immunosorbent assay (ELISA) technique.  Antigen 
was adsorbed onto Immulon microtiter plates (Dynatech Laboratories, Inc., Alexandria, 
VA) by incubation of 10 ~g]ml of antigen in 0.05 M NaHCO~, pH 9.6, for 18 h. After 
extensive washing of the wells with PBS/1% fetal calf serum (FCS), a  100-#1 aliquot of the 
antiserum or doubling dilutions of the antiserum was added to individual wells. The wells 
were  then  filled  with  200  IA of PBS/I%  FCS.  Following  a  2.5-h  incubation  at room 
temperature, the wells  were emptied, washed, and refilled with 300 ~1 of a rabbit anti- 
mouse Ig alkaline phosphatase conjugate optimally diluted in PBS/1%  FCS. Following a 
second 2.5-h  incubation,  the wells  were washed and refilled with  300 #1 p-nitrophenyl 
phosphate (Sigma Chemical Co.), 0.2  mg/ml, dissolved in 0.1  M Tris-Cl buffer, pH  10. 
The optical density at 410 nm was determined with an automatic microplate reader (MR 
600; Dynatech Laboratories, Inc.) after an appropriate incubation period. The reported 
titers are the end dilutions of the antiserum,  which yield essentially prebleed levels of 
reactivity. The titers shown in all data tables reflect the average response based on pooled 
bleeds of four animals per group. 
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conjugate was prepared as follows. Mouse IgG, purified by DEAE cellulose and protein 
A (Pharmacia Fine Chemicals) chromatography, was used to immunize  rabbits. The rabbit 
antiserum was purified by affinity chromatography on CM-Bio Gel (Bio-Rad Laboratories, 
Inc.,  Richmond,  CA)  coupled  mouse  IgG.  The  enzyme-labeled rabbit  antibody was 
prepared by the procedure of Avermeas (19). Briefly, one part of affinity-purified  antibody 
was mixed with three parts of alkaline phosphatase (Sigma Chemical Co.) in PBS and 
glutaraldehyde was added to a  final concentration of 0.05%. After 2  h  incubation, the 
mixture was exhaustively dialyzed, filter-sterilized, and stored at 4°C in 50% glycerol. 
Results 
PT to Protein Antigens.  UV-induced unresponsiveness to protein antigens is 
shown in Table I.  Three comparisons should be noted. First, mice, skin-primed 
and  challenged  (groups  3,  7,  1 I,  and  15),  respond  to  the  antigens.  Second, 
normal and  UV-irradiated  mice exhibit equivalent responses to systemic chal- 
lenge (groups 1, 2, 5, 6, 9,  10,  13, and  14). This indicates that the dose of UV 
radiation employed does not by itself cause immune suppression. Third, sensiti- 
zation through the UV-irradiated skin site followed by intraperitoneal (or intra- 
venous; data not shown) challenge fails to elicit an antibody response (groups 4, 
8,  12,  and  16);  that  is,  it  results  in  PT.  These results  demonstrate  that  skin 
sensitization through irradiated skin sites effectively inhibits responses to subse- 
quent  systemic antigen  challenge.  Unresponsiveness, caused  by  some  type of 
suppression, is apparent because mice subjected to PT respond less than normal 
or UV-irradiated control mice. 
To demonstrate that the effects of UV irradiation were directly related to the 
exposed skin site, experiments were performed in which mice were skin-sensitized 
at different sits.  Our results suggest that PT is detected only if the antigen is 
introduced through UV-irradiated skin (Table II).  Further, as shown in Table 
TABLE  I 
PT to Protein Antigens 
Skin sensi- 
Group  Mice  Antigen  UV  tization  Challenge  Titer 
1  4 C3H*  HulgG*  +  40 
2  +  +  40 
3  +  +  1,280 
4  +  +  +  0 
5  4 BALB/c  +  20 
6  +  +  4O 
7  +  +  640 
8  +  +  +  0 
9  4 C3H  RablgG  +  20 
10  +  +  2O 
11  +  +  160 
12  +  +  +  0 
13  CALB  +  20 
14  +  +  20 
15  +  +  160 
16  +  +  +  0 
* Animals were UV-irradiated on days 0-4, skin-sensitized on day 4, challenged on day 8, and bled 
on day 14. 
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TABLE  II 
Induction of PT by Sensitization through UV-irradiated or Distant Skin Sites 
Sensitization 
Group  Mice  UV  site  Challenge  Titer 
1  4 C3H*  +  40 
2  Dorsal  +  1,280 
3  Ventral  +  1,280 
4  +  (Dorsal)  Dorsal  +  0 
5  +  (Dorsal)  Ventral  +  1,280 
* Animals were UV-irradiated on days 0-4, skin-sensitized on day 5, challenged on day 
9, and bled on day 14. The antigen was HulgG. 
TABLE  III 
Effects of Sensitization by Various Routes on PT Induction 
Sensitization 
Group  Mice  UV  Intrader-  Subcuta-  Challenge  Titer 
Cutaneous  real  neous 
1  4 C3H*  +  40 
2  +  +  1,280 
3  +  +  1,280 
4  +  +  640 
5  +  +  +  0 
6  +  +  +  ! ,280 
7  +  +  +  1,280 
* Animals were UV-irradiated on days 0-4, sensitized by scarification, or intradermal or subcutaneous 
injection on day 5, challenged on day 9, and bled on day 13. The antigen was HuIgG. 
TABLE  IV 
Induction of PT with Different Doses of UV Radiation 
UV (days)  Skin sensi- 
Group  Mice  Challenge  Titer 
1  3  4  5  7  25  40  tization 
1  4 C3H*  +  80 
2  +  +  1,28O 
3  +  +  +  1,280 
4  +  +  +  0 
5  +  +  +  0 
6  +  +  +  0 
7  +  +  +  20 
8  +  +  +  4O 
9  +  +  +  160 
* Animals were UV-irradiated for the number of days indicated, skin-sensitized on the day after the 
last UV exposure,  challenged 5  d  after sensitization, and bled  10 d  after sensitization. Starting 
times for irradiation were staggered so that all groups finished simultaneously. The antigen was 
HuIgG. 
III,  the  sensitization  must  be  via  the  cutaneous  route.  If  antigen  is  injected 
intradermally  or subcutaneously,  priming  occurs. 
The  induction  of  PT  in  mice  receiving  different  amounts  of  UV  irradiation 
(Table  IV) suggests that at least 3  d  of exposure  is necessary  for unresponsiveness SPELLMAN  ET  AL.  1895 
to occur. Mice irradiated for N6 wk appear to be recovering the capacity to be 
primed through the skin. This observation parallels the data from DTH experi- 
ments, which also suggest that chronically irradiated mice recover the ability to 
be skin-sensitized (3).  The data shown in Table V address two questions. First, 
how much time can elapse after PT  induction before systemic challenge with 
antigen again results in a  response? Our results indicate that responsiveness is 
manifest if the challenge is  delayed ~2  wk after  PT  induction (see Table  V, 
groups 4-8). Second, how much time can elapse between the termination of UV 
exposures and skin sensitization for PT to be induced? It appears that PT occurs 
if the  animal  receives antigen  within  2  wk after  cessation  of UV  exposures 
(groups 9-12). 
While  PT  can  inhibit  primary responses,  it  does  not appear  to  reverse an 
ongoing response.  The experiment illustrated in  Table VI  was performed by 
first injecting the mice intraperitoneally with antigen and then subjecting them 
to the PT induction regimen. As shown, PT has no effect on the efferent phase 
of the antibody response. 
Evidence was obtained that PT is antigen specific. The data presented in Table 
VII are based on immunizations with human IgG and conalbumin because these 
proteins do not elicit cross-reactive responses in the controls after primary or 
secondary encounter with the antigens (groups 9, 10, and 1-4). The experimental 
groups show that PT is induced in both antigen systems (groups 5 and 7), but 
that PT to one antigen does not inhibit the response to systemic challenge with 
the other antigen (groups 6 and 8). Because conalbumin is a weak antigen in this 
immunization regimen, specificity experiments were also performed with puri- 
fied rabbit IgG, and similar results were obtained (data not shown). 
TABLE  V 
Effects  of Altering Time of Sensitization or Challenge on PT Induction 
Skin sensitiza- 
tion  Challenge 
Group  Mice  UV  (Days after  (Days after  Titer 
UV irradia- 
tion)  sensitization) 
1  4 C3H*  +  40 
2  +  24  1,280 
3  +  4  1,280 
4  +  1  24  1,280 
5  +  1  18  1,280 
6  +  1  14  320 
7  +  1  10  0 
8  +  1  4  0 
9  +  4  4  0 
10  +  5  4  0 
11  +  10  4  20 
12  +  16  4  640 
* Animals were  UV-irradiated on  days  0-4,  skin-sensitized on  day  1,  4,  5,  10,  or  16  after  UV 
irradiation, challenged on day 4, 10,  14,  18, or 24 after sensitization, and bled 5 d after challenge. 
Control groups  1-3  received no  UV radiation.  Group  1 received only intraperitoneal antigen 
challenge. Groups 2 and 3 were skin-sensitized and challenged either 24 or 4 d later, respectively. 
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TABLE  VI 
Induction of PT Does Not Inhibit an Ongoing Primary or Secondary 
Response 
Chal- 
Group  Mice  lenge  UV  Skin sensi- 
tization  Titer 
1  2 
1  4 C3H*  +  40 
2  +  +  40 
3  +  +  +  40 
4  4 C3H*  +  +  64O 
5  +  +  +  1,280 
6  +  +  +  +  640 
* Animals were challenged intraperitoneally on day 0, UV-irradiated on days 1  - 
4, skin-sensitized through the irradiated skin site on day 5, and bled on day 
10. 
* Animals were challenged intraperitoneally on days 0 and 9, UV-irradiated on 
days 5-9, skin-sensitized through the irradiated skin site on day 10, and bled 
on day 14. The antigen HulgG was used in both experiments. 
TABLE  VII 
Specificity of PT 
Skin sensitiza- 
Group  Mice  UV  tion  Challenge 
Titer 
HuIgG  CALB 
1  4 C3H*  CALB  CALB  0  160 
2  CALB  HuIgG  20  0 
3  HulgG  HulgG  1,280  0 
4  HuIgG  CALB  320  10 
5  +  CALB  CALB  0  0 
6  +  CALB  HuIgG  40  0 
7  +  HulgG  HulgG  0  0 
8  +  HulgG  CALB  0  5 
9  --  CALB  0  10 
10  --  HuIgG  40  0 
* Animals were UV-irradiated on days 0-4, skin-sensitized on day 5, challenged on day 9, and bled 
on day 16. The antigens were CALB and HuIgG. 
TABLE  VIII 
Response to Multiple Cutaneous  Sensitizations  in Phototolerized Mice 
Group  Mice  UV 
Skin sensitiza-  Titer  tion 
1  2  3  1  2  3  4 
1  4 C3H*  +  +  +  0  20  2,560  2,560 
2  +  +  +  +  5  0  0  0 
* Animals were UV-irradiated on days 0-9, skin-sensitized on days 5, 9, and 13, and bled on days 9, 
13,  17, and 25. The antigen was HulgG. SPELLMAN ET  AL. 
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Skin  sensi-  Group  Mice  UV  tization 
Challenge  Titer 
1  2  3  1  2  3 
1  4 C3H*  +  +  +  20  160  1,280 
2  +  +  +  +  20  160  1,280 
3  +  +  +  +  160  640  2,560 
4  +  +  +  +  +  0  320  640 
* Animals were UV-irradiated on days 0-4, skin-sensitized on day 4, given multiple challenges on 
days 8, 11, and 15, and bled on days 11, 15, and 18. The antigen was HulgG. 
TABLE X 
Response to HulgG in Mice Phototolerized Before Each Challenge 
Skin sensitization  Challenge  Titer 
Group  Mice  UV 
1  2  3  1  2  $  Day 14  21  27 
1  4 C3H*  +  +  +  80  1,280  2,560 
2  +  +  +  +  +  +  640  2,560  2,560 
3  +  +  +  +  +  +  +  0  0  160 
UV 
I  I  i  I  I 
1 
6  10  13  14  17  18  30 
i  i  i  l  i  I  t  i  ~  i  i  i  I  l  l  i  I 
1  I  ]  I  1  1  Senl  Chl  B  1 
Sen 2  Ch 2 
Sen 3 
21  23  27 
i' 
Ch3  BI 3 
Days 
* Animals were  UV-irradiated on days  1-18. skin-sensiti~-n:l  with HulgG on days 6,  13, and 18, challenged intraperitoneally with  HulgG on 
days 10, 17, and 23, and bled on days  14.21, and 27. 
The data presented above (Tables I-IV, VI, and VII) were derived from single 
sensitization  and  challenge  procedures  within  a  2-wk  time  frame.  We  also 
examined the effects of PT  when antigen was repeatedly administered either 
intradermally or  systemically. The  results  shown  in  Table  VIII  indicate  that 
multiple  skin  sensitization  in  normal  controls  leads  to  vigorous  antibody  re- 
sponses. However, if the sensitizations are performed on UV-irradiated skin, no 
reponse is elicited. Multiple challenges following a single PT regimen (Table IX) 
suggest  that  the  unresponsiveness  is  short-lived.  Specifically,  no  response  is 
detected  in  the  phototolerized  mice  after  the  first  challenge,  but  successive 
challenges result in the emergence of a response (Table IX, group 4). In contrast, 
if sensitization through a  UV-irradiated  skin site precedes  each challenge,  the 
antibody response is maintained at a low level (Table X). 
Discussion 
Several conclusions can be drawn from these studies. (a)  PT can be demon- 
strated in C3H and BALB/c mice to several antigens, including both aggregated 
and deaggregated Ig. (b) PT induction is restricted to the irradiated skin site. (c) 
PT  is elicited only if sensitization with antigen is via the cutaneous route.  (d) 
Approximately 3-4  d  of UV  irradiation is sufficient for PT  induction. (e)  PT 
appears to be a  short-lived phenomenon. Thus, suppression  is observed only if 1898  UV-INDUCED  PHOTOTOLERANCE  OF  ANTIBODY  RESPONSES 
antigen challenge is given within 2 wk of sensitization and if skin sensitization is 
performed within 10 d of the UV irradiation. (f) If animals have been previously 
immunized, PT induction cannot inhibit an ongoing response. (g) PT appears 
to be antigen specific. (h)  If antigen is given multiple times through the skin, 
UV-irradiated hosts do not appear to mount a response. If hosts are phototoler- 
ized once, subsequent systemic challenge with antigen multiple times will elicit a 
response.  However, if PT induction is performed prior to each challenge, the 
response is maintained at a low level. 
The mechanisms underlying PT are unknown. It appears that PT may involve 
a  failure to prime for a  response. This hypothesis is based on the observations 
that repeated cutaneous sensitizations through a  UV-irradiated skin site do not 
elicit a  response,  but  sensitization  at  a  distant  skin  site  during  PT  induction 
clearly elicits antibody. Further, multiple systemic challenges after PT eventually 
lead to specific antibody production. The emergence of this response is delayed, 
and when it appears, it resembles a primary response in that it is predominantly 
IgM (55-60%;  data not presented). Thus,  the animal does not respond to the 
sensitization, but can respond to some degree to the systemic challenge. 
A defect in antigen presentation has a precedent in investigations of antigen- 
presenting cell function in  UV-irradiated mcie (1,  9,  20-25).  Other work (26, 
27) has implicated antigen-specific suppressor cells in  UV-induced DTH toler- 
ance. Our attempts to demonstrate active suppression have included the use of 
adoptive  transfer  experiments  and  cyclophosphamide  pretreatments  (28)  to 
reverse  PT  induction.  Cyclophosphamide  (200  mg/kg),  administered  1-3  d 
before the initiation of UV irradiation, or  1-3  d  before skin sensitization, was 
ineffective in  restoring competence. Adoptive transfer experiments, using 5  x 
107 cells from tolerant animals injected into normal syngeneic mice, also failed 
to demonstrate suppressor cells. Whole spleen, regional lymph node cells, and 
nylon-column-purified T  cells from these tissues were used. Also, serum, does 
not appear  to  transfer suppression.  Perhaps,  however, UV  irradition  induces 
several defects and suppression may be observable only in a "prepared" host (4, 
11,  27).  Experiments currently in  progress,  using  UV-irradiated recipients of 
transferred cells, suggest that a suppressor cell component may be present. 
A potentially important practical application of this study is the induction of 
tolerance to foreign proteins. One of the major problems of therapy with mouse 
monoclonal antibodies is the eventual formation of an anti-mouse Ig response 
that  not  only  limits  the  effectiveness of the  therapeutic  antibody,  but  also 
introduces the danger of an allergic response. Similar problems are encountered 
when other proteins (enzymes, hormones, etc.), derived from foreign species, 
are  used  in  prolonged  treatment  regimens.  Our  data  suggesting  that  small 
localized doses of UV plus "antigen" (given before each injection) can maintain 
tolerance are encouraging. We are currently investigating whether PT and high 
intravenous  doses  of antigen  (simulating  the  condition  used  in  monoclonal 
antibody therapy) may be effective in maintaining tolerance over long periods. 
Finally,  it  will  be  important  to  determine if soluble  forms of transplantation 
antigens applied in a  PT regimen induce sufficient suppression of the immune SPELLMAN ET  AL.  1899 
response to be beneficial in organ transplantation.  PT early in transplantation 
may prevent early rejection and allow other mechanisms of tolerance to become 
established. 
Summary 
C3Hf/HeN  or  BALB/c mice,  exposed  to acute  ultraviolet (UV)  irradiation 
and skin-sensitized through the irradiated skin site with soluble protein antigens, 
exhibit humoral  tolerance to subsequent  systemic challenge with antigen.  We 
have termed  this phenomenon  "phototolerance" (PT).  With  the doses  of UV 
radiation used, PT induction is retricted to the irradiated skin site and is observed 
only if sensitization is performed via the cutaneous route. PT is antigen specific 
and  operates  at  the  afferent level Of the  immune  response.  While  single  PT 
induction regimens result in transient humoral suppression, multiple inductions 
before  each  systemic challenge  can  maintain  the  response  at  low  levels.  The 
capacity to induce PT to a variety of soluble protein antigens may have potentially 
important clinical applications. 
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